Respiratory Infections News

A “marked decrease” in respiratory virus detections correlated with a 79% reduction in ambulatory antibiotic prescribing rates for respiratory tract infections during the COVID-19 pandemic, researchers of a pre-post study wrote.

The economic and societal impacts of emerging infectious diseases remain ever present, with COVID-19 being at the forefront.

My initial fascination with infectious diseases began as it did for many others: through the influence of my parents and exposure through books.

Long-term infrastructure and short-term interventions had the biggest impact on reducing COVID-19 deaths in the United States during the first wave of cases, according to new research.

Almost a quarter of adults aged 18 to 39 years indicated they would not get vaccinated against COVID-19, researchers reported today in MMWR.

Researchers said four cases of oseltamivir-resistant influenza A(H1N1) were detected at a border detention center in Texas with hemagglutinin that belong to a subclade that may enable viral escape from pre-existing immunity.

As of June 16, more than half of Americans were fully vaccinated against COVID-19, including more than 76% of adults aged 65 years or older.

CureVac said its COVID-19 vaccine candidate was 47% efficacious against disease of any severity in a phase 2b/3 trial that took place “in the unprecedented context of at least 13 variants circulating within the study population.”

Regeneron’s antibody cocktail reduced the risk for death by 20% in patients hospitalized with severe COVID-19 who had not mounted their own immune response, researchers from the phase 3 RECOVERY trial said Wednesday.

The AMA has approved new policies that aim to expand telehealth access, support struggling hospitals in rural areas and distribute COVID-19 resources to underserved communities.